Loes Hollestein

Dr. Loes Hollestein is an Assistant Professor in the Department of Dermatology at Erasmus MC, a prominent medical center in the Netherlands. She also holds an external position as a Researcher at the Netherlands Comprehensive Cancer Organization (IKNL) since June 2015. Her academic work focuses on skin cancer epidemiology and prediction models.

Dr. Hollestein's research primarily centers on the epidemiology of skin cancers, with particular expertise in melanoma, cutaneous squamous cell carcinoma, and basal cell carcinoma. Her work investigates the prediction of multiple skin cancers and metastasis, contributing significantly to understanding cancer progression and risk factors. She has developed expertise in cohort analysis, cancer registry research, and actinic keratosis studies, forming a comprehensive approach to skin cancer epidemiology.

Her recent publications demonstrate a growing integration of artificial intelligence in dermatological research, particularly for early detection of metastatic cutaneous squamous cell carcinoma and automated assessment of skin histological structures. Dr. Hollestein's work spans population-based studies across the Netherlands, examining skin cancer risks in various patient populations including those with hematological malignancies. Her research portfolio shows a consistent focus on improving detection methods, understanding risk factors, and evaluating treatment approaches for various skin cancers.

Dr. Hollestein has received attention for her work, with several publications picked up by news outlets and discussed on social media platforms. Her research outputs have been cited and captured the interest of readers on academic platforms like Mendeley.

As a supervisor, Dr. Hollestein has guided four supervised works, contributing to the development of the next generation of researchers in dermatology and oncology. Her collaborative approach is evident in her numerous co-authored publications with researchers across various specialties.

Dr. Hollestein's laboratory and research team focus on epidemiological studies of skin cancer, utilizing large population datasets and cancer registries. Her work contributes to Sustainable Development Goals related to good health and well-being, particularly in cancer research and prevention.